WASHINGTON--Zeneca Pharmaceuticals and its National Breast Cancer Awareness Month (NBCAM) co-sponsors have presented First Lady Hillary Rodham Clinton with the Government Leadership Award for her outstanding initiative in launching efforts to educate women about mammography.
WASHINGTON--Zeneca Pharmaceuticals and its National Breast CancerAwareness Month (NBCAM) co-sponsors have presented First LadyHillary Rodham Clinton with the Government Leadership Award forher outstanding initiative in launching efforts to educate womenabout mammography.
Special awards were given to three sets of "partners"who have played pivotal roles in breast cancer awareness: formerFirst Lady Betty Ford and her daughter Susan Ford Bales; NancyBrinker and, posthumously, her sister, Susan G. Komen; and HarveyKushner and, posthumously, his wife, Rose.
Community outreach programs honored were Carilion Health System,Roanoke, Va; Emory University School of Medicine; and HartfordHospital.
Awards for achievement in providing employees access to breastcancer screening and education at the worksite went to MetrolinaOutreach Mammography, Charlotte, NC, and Tri Valley Growers, SanFrancisco.
In the print media category, Oncology Times received an awardfor its stories on the National Surgical Adjuvant Breast and BowelProject.
Primary Care & Cancer, under the editorial directionof James McCarthy and published by PRR, Inc. (which also publishesthe journal Oncology and Oncol-ogy News International), was honoredfor its Breast Self-Examination Guide, and John Gentile, Jr.,president of PRR, won an Awareness Achievement Award (see photographbelow), which he accepted on behalf of the entire staff.
Ribociclib Combo Yields iDFS Improvement in HR+/HER2– Breast Cancer
December 9th 2023Combining ribociclib with nonsteroidal aromatase inhibitor treatment also produces relapse-free survival and distant disease-free survival benefits in patients with HR-positive, HER2-negative early-stage breast cancer.
Experts Discuss Differences in Radiotherapy Outcomes in BRCA+ Breast Cancer
October 30th 2023Rebecca M. Shulman, MD, and Zachary Kiss, DO, discuss findings from a study evaluating differences in outcomes with radiotherapy and disease characteristics of patients with breast cancer harboring BRCA mutations compared with those without mutated disease.
Oncology On-The-Go Podcast: De-escalating Breast Cancer Treatment
May 8th 2023Rakhshanda Rahman, MD, FRCS, FACS, emphasizes the importance of educating patients and physicians on the potential risks and benefits of new approaches and technologies involved in the de-escalation of breast cancer treatment.